Comparison 6. LMWH versus subcutaneous UFH in patients with venous thromboembolism.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Incidence of recurrent venous thromboembolism at the end of follow‐up	3	1403	Peto Odds Ratio (Peto, Fixed, 95% CI)	1.05 [0.56, 1.95]
2 Incidence of major haemorrhagic episodes (during initial treatment)	4	1471	Peto Odds Ratio (Peto, Fixed, 95% CI)	0.91 [0.50, 1.67]
3 Overall mortality at the end of follow‐up	3	1403	Peto Odds Ratio (Peto, Fixed, 95% CI)	1.46 [0.91, 2.35]